Actos and Spleen disorder - a phase IV clinical study of FDA data

Summary:

Spleen disorder is reported as a side effect among people who take Actos (pioglitazone hydrochloride), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Lantus, and have Metastases to bone.

The phase IV clinical study analyzes which people have Spleen disorder when taking Actos. It is created by eHealthMe based on reports of 49,087 people who have side effects when taking Actos from the FDA, and is updated regularly.

What is Actos?

Actos has active ingredients of pioglitazone hydrochloride. It is often used in diabetes. eHealthMe is studying from 49,754 Actos users. Check the latest studies of Actos.

What is Spleen disorder?

Spleen disorder (disease of spleen) is found to be associated with 383 drugs and 409 conditions by eHealthMe. Check the latest studies of Spleen disorder.

On Jul, 09, 2026

49,087 people reported to have side effects when taking Actos.
Among them, 18 people (0.04%) have Spleen disorder.

Among these 18 people:

How long have people been on Actos when they have Spleen disorder? *

What is the gender of people who have Spleen disorder when taking Actos? *

female: 11.11 %
male: 88.89 %

What is the age of people who have Spleen disorder when taking Actos? *

What are other drugs people take besides Actos? *

What are other side effects people have besides Spleen disorder? *

Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 12 people, 66.67%
Nausea (feeling of having an urge to vomit): 11 people, 61.11%
Hypoaesthesia (reduced sense of touch or sensation): 10 people, 55.56%
Gastroenteritis Radiation (radiation induced inflammation of stomach and intestine): 10 people, 55.56%
Groin Pain: 10 people, 55.56%
Haematuria (presence of blood in urine): 10 people, 55.56%
Hair Loss: 10 people, 55.56%
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle): 10 people, 55.56%
Hydrocele: 10 people, 55.56%
Jaw Fracture: 10 people, 55.56%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 10 people, 55.56%
Metastases To Bone (cancer spreads to bone): 10 people, 55.56%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.56%
Lipid Metabolism Disorder (genetic disorders are caused by errors in fatty acid metabolism): 1 person, 5.56%
Insomnia (sleeplessness): 1 person, 5.56%
Gastritis (inflammation of stomach): 1 person, 5.56%
Diabetes Mellitus Inadequate Control: 1 person, 5.56%
Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Actos and have Spleen disorder?

- Check whether Spleen disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Actos:

Actos (49,754 reports)

Spleen disorder treatments and more:

Spleen disorder (2,370 reports)

Browse all side effects of Actos:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Spleen disorder:

Spleen disorder (383 drugs)

Browse all the conditions that are associated with Spleen disorder:

Spleen disorder (409 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pioglitazone hydrochloride (the active ingredients of Actos) and Actos (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.